香港股市 已收市

Cardiff Lexington Corporation (CDIX)

Other OTC - Other OTC 延遲價格。貨幣為 USD。
加入追蹤清單
4.00000.0000 (0.00%)
收市:09:38AM EDT

Cardiff Lexington Corporation

3753 Howard Hughes Parkway
Suite 200
Las Vegas, NV 89169
United States
844 628 2100
https://www.cardifflexington.com

版塊Financial Services
行業Asset Management
全職員工13

高階主管

名稱頭銜支付行使價出生年份
Mr. Daniel R. ThompsonChairman of the Board & Secretary610k1949
Mr. Alex H. CunninghamCEO, President & Director610k1956
Ms. Zia Choe CPAChief Accounting Officer145.05k1982
Mr. Matthew T. ShaferSenior VP, CFO & Treasurer1971
Dr. Kevin Fitzgerald M.D.Managing Director of Nova Ortho & Spine
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Cardiff Lexington Corporation, together with its subsidiaries, operates in health care business in the United States. The company Healthcare, and Real Estate segments. It also provides tax resolution service to individuals and companies that have federal and state tax liabilities; and a range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. In addition, the company engages in the commercial real estate property business. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018. Cardiff Lexington Corporation is based in Las Vegas, Nevada.

公司管治

截至 無 止,Cardiff Lexington Corporation 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。